NEWS

Developing a promising biologic candidate is only the first step on the long path to delivering a safe, effective, and commercially...

Safeguarding safety and efficacy from day one Failing to clearly define quality targets early in biotech development can have serious...

Drug development is an inherently high-stakes endeavour, with failure rates in early phases reaching up to 90%. For emerging biotech...

The good news? There’s still plenty of opportunity for companies that prepare well. Here’s what biotech startups need to know to attract...

Why biotech companies need the right CDMO partner Biotech companies - particularly early-stage or small-to-mid-sized firms - often face...

In recent years, Artificial Intelligence (AI) has begun to play a transformative role in the biotechnology and pharmaceutical industries....

Biotech innovation doesn’t happen in a vacuum. Behind every successful molecule reaching clinical trials is a seamless CMC strategy...

Olivier Favre-Bulle, founder of 3Biotech , shares his insights on the pressures facing the French biotech sector and the opportunities...

A roadmap for success in Biotech The development of biotech and biological medicines is a highly complex process that goes beyond...

A Vision to Revolutionize CMC Support for Early-Stage Biotech Founded by Olivier Favre-Bulle in 2014, 3Biotech was born from the desire...

A well-structured Chemistry, Manufacturing, and Controls (CMC) strategy is essential for the successful development of biologics. For...

3Biotech has announced a new collaboration with Cartelis, a data and CRM operational consulting firm, to explore innovative ways to ...

Founder and CEO of 3Biotech, Olivier Favre-Bulle was awarded the "Cercle des experts Bpifrance" label at the 9th edition of the BIG...

Valuable conversation between Elio di Rupo, Minister-President of Wallonia and former Prime Minister of Belgium, ...

Dominique Demonte, Head of the Brussels South Charleroi BioPark (Belgium) and Catherine Muller, Executive VP at 3Biotech, have ...

3biotech joins BioWin, Wallonia's biotech research organization...

CIS BIOPHARMA is the Basel-based 2023 oncology spinoff from CIS Pharma. Christoph Schäfer,CEO of CIS Pharma, talks about his...

Backed by 3Biotech, Nantes-based start-up Abcely, which offers a unique approach to the treatment of mucosal cancers, ...

Karla Therapeutics is the first "T cell company" aiming to improve mental health. Its drug development program relies ...

Epynext Therapeutics is dedicated to the fight against antibiotic resistance, one of the most urgent health threats of our time ...

Interview with Gilles Avenard, co-founder and CEO of Acticor Biotech...